Substituted quinazolines as inhibitors of KRAS G12C

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9840516
SERIAL NO

14511425

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ARAXES PHARMA LLC3033 SCIENCE PARK ROAD SUITE 220 SAN DIEGO CA 92121

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Feng, Jun San Diego, US 210 4080
Li, Liansheng San Diego, US 158 5429
Liu, Yi San Diego, US 838 10296
Liu, Yuan San Diego, US 306 2821
Long, Yun Oliver San Diego, US 27 1147
Ren, Pingda San Diego, US 198 6390
Wu, Tao Carlsbad, US 372 4736

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 12, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 12, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00